Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Playground Global Raises $410 Million to Accelerate the Time-to-Impact for Deep Tech and Science Companies
Life Sciences Times
-
December 14, 2023
0
Venture Capital
Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth
Life Sciences Times
-
December 14, 2023
0
Venture Capital
Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders
Life Sciences Times
-
December 13, 2023
0
People on the Move
Great Point Partners Announces Growth Investment of Ludi, Inc.
Life Sciences Times
-
December 13, 2023
0
Venture Capital
Medefy Health Raises $10 million Series A Funding to Deliver Real-Time Healthcare Benefits Navigation through Human-Led Support
Life Sciences Times
-
December 11, 2023
0
Venture Capital
Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale
Life Sciences Times
-
December 11, 2023
0
Venture Capital
BioStar Capital Closes Fund V at $130.3 Million, Surpassing Previous Funds
Life Sciences Times
-
December 6, 2023
0
Venture Capital
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines
Life Sciences Times
-
December 6, 2023
0
Venture Capital
Seismic Therapeutic Closes $121 Million Series B Financing to Advance Immunology Pipeline Optimized by its Machine Learning Platform
Life Sciences Times
-
December 4, 2023
0
Venture Capital
PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform
Life Sciences Times
-
December 4, 2023
0
Venture Capital
Intuitive Ventures Closes $150 Million Fund II to Continue Investment in Startups Reimagining Minimally Invasive Care
Life Sciences Times
-
December 4, 2023
0
Venture Capital
Perpetual Medicines Completes $8 Million Seed Round to Advance Integrated Computational Design-Synthesis Platform for Peptide Drug Discovery
Life Sciences Times
-
December 1, 2023
0
1
...
36
37
38
...
115
Page 37 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026